UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000031584
Receipt No. R000035952
Scientific Title Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1-negative or weakly positive advanced non-small-cell lung cancer after disease progression on platinum-based therapy. (EMERALD study) (WJOG10317L)
Date of disclosure of the study information 2018/03/05
Last modified on 2019/09/06 09:09:52

No. Disposal Last modified on Item of update
1 Insert 2018/03/05 14:12:08
2 Update 2018/03/05 16:09:37 Key inclusion criteria
3 Update 2018/03/27 18:06:49 Anticipated trial start date
4 Update 2019/03/06 09:25:45 Recruitment status
5 Update 2019/09/06 09:09:52 Date of IRB
Last follow-up date

Contact us.